Sangamo Therapeutics, Inc.
Methods and compositions for treating hemophilia
Last updated:
Abstract:
Disclosed herein are methods and compositions for insertion of transgene sequences encoding proteins involved in clotting into the genome of a cell for treating conditions including hemophilias.
Status:
Grant
Type:
Utility
Filling date:
9 Aug 2017
Issue date:
10 Sep 2019